Teneglide 20 Tablet contains Teneligliptin 20mg, a DPP-4 inhibitor used in the management of type 2 diabetes mellitus. It helps in improving glycemic control by increasing endogenous incretin levels, thereby enhancing insulin secretion and suppressing glucagon release in a glucose-dependent manner.
Teneligliptin works by inhibiting the dipeptidyl peptidase-4 enzyme, prolonging the action of incretin hormones such as GLP-1 and GIP. This results in better post-prandial and fasting blood glucose control with a low risk of hypoglycemia when used alone.
Clinically, Teneglide 20 Tablet is indicated for patients with type 2 diabetes who do not achieve adequate glycemic control with diet and exercise alone. It may be prescribed as monotherapy or in combination with other antidiabetic agents, depending on patient needs. The tablet form ensures convenient once-daily dosing and good patient compliance.
Regular use under medical supervision helps in maintaining stable blood glucose levels, reducing long-term diabetic complications, and improving overall metabolic health. Teneglide 20 Tablet is a trusted choice in modern diabetes management, offering efficacy, safety, and ease of use.